LiquidMetal Technologies has been rumored by many sources to be Apple’s solution to the hinge problem experienced by other companies producing folding phones. If it’s used, it’s uncertain whether the contract for the hinges went through LiquidMetal or one of its partners, but it would be manufactured by Eontec or Yihao, both companies strongly associated with LQMT’s COB Lugee Li. Li has been CEO of both companies and still holds interest in both, but he just resigned as CEO of Yihao to start up LiquidMetal’s own manufacturing facility capable of holding at least 40 of their state of the art LiquidMorphium machines in a 40,000+ square foot expandable facility. This means that LiquidMetal is poised to derive revenue from IP licensing, manufacturing, and selling LiquidMorphium machines. LiquidMorphium is their new company where new LiquidMetal IP will reside. The future has never looked brighter for the company.

If Apple mentions Liquidmetal next week during the introduction of its folding phone, there will be millions of eyes on the company and the stock will blast off. If they don’t mention the company by name but LiquidMetal is confirmed to be used, the stock will still climb because Apple used them as a solution provider and a trusted partner. This will open up the flood gates for new products in aerospace, medical, automotive, and consumer electronics.

Lugee Li did not sell controlling interest in Eontec to buy into LQMT or leave Yihao on a lark for a “build it and they will come scenario”. He is an expert in setting up successful manufacturing and probably has contracts in hand. I believe that this material is a major industry disrupter and will be the “plastics” story of the 21st century. You might search the Reddit sub for this company to gain more detailed information.

Full disclosure: my LQMT holdings are in the seven figures and have been accumulating for over ten years. I’m excited that this is all coming together at this moment. When I wrote about this stock here the last time, I think it was about a dime a share. Now it’s at about 24 cents. This may be the last chance of buying into the company at these prices. Li has stated his goal is NASDAQ ($4/share). I think it’s worth your consideration and time spent doing some DD.

RVVTF — Revive Therapeutics: The peptide lesson Big Pharma is about to learn the hard way.

Eli Lilly just sued six companies for selling unapproved retatrutide. The drug hasn’t even finished Phase 3 yet, and the black-market peptide trade is already worth billions. That’s the tell. The multi-trillion-dollar peptide era is here, and the giants are scrambling because they lost control of the patents.

Peacetime bucillamine rights are a $5M option. A live chemical-threat scare in the Middle East is the one thing that turns it into a 90-day exclusivity check plus government-funded Animal Rule work. The science does not get better overnight. The buyer’s fear of being late does.

Not financial advice. Scenario, not news.

IMO: Bucillamine is the next one they should be eyeing and buying cheap right now.

Revive holds the rights. Granted Canadian Patent 3,172,170 covers bucillamine for infectious diseases — influenza, COVID-19 — expiring 2041. Fresh U.S. and Canadian filings under application 19/518,001 target nerve-agent exposure. There’s also a granted U.S. patent for gout and additional filings for stroke, brain injury, and migraines.

This isn’t theoretical. Bucillamine has over thirty years of clinical use in Japan and South Korea for rheumatoid arthritis. It’s a stronger antioxidant than NAC. And the latest animal data from Defence Research and Development Canada shows it preserved key brain receptors in nerve-agent models while avoiding the pulmonary hemorrhage seen with NAC.

That’s exactly the profile governments stockpile for. Canada and the U.S. already run biodefense programs. Middle East allies facing ongoing conflict need the same countermeasures. Revive is positioned for those contracts.

Market cap sits around nine million dollars. The asset is real, the IP is expanding, and the window for Big Pharma to lock in exclusive rights is closing fast — just like it did with the peptides.

The largest cartel in the world lost the ability to patent 100s of peptides. Small Compounding Pharmacies beat them to the punch.

Any smart, BIG Pharma market analysis, executives would be foolish not to believe "animal" data for efficiency based on bucillamine existing safety profile. Big Pharma owes this shareholders and remember the history lesson. War always brings profit for the right ones prepared and controlling it.

TheNewswire)

One World Lithium Inc.

VANCOUVER, BC August 28, 2026 TheNewswire - One World Lithium Inc. (CSE-OWLI) (the "Company" or "OWL") is pleased to announce that, further to its news release dated July 24, 2026, the Company has closed the first tranche of its previously announced $910,000 non‑brokered private placement (the "Offering"), issuing units (each, a "Unit") of the Company for aggregate gross proceeds of $264,150 (the "First Tranche").

In connection with the closing of the First Tranche, the Company issued an aggregate of 7,547,142 Units at a price of $0.035 per Unit. Each unit consisted of one common share (each, a "Share") and one-half non-transferable share purchase warrant (each, a "Warrant"), with each Warrant being exercisable to purchase one additional Share at a price of $0.08 for 36 months from the date of issuance.

The Company intends to use the net proceeds of the Offering for advancing its patent‑pending lithium extraction technologies, including continued laboratory testing, engineering evaluation and working capital purposes.

An officer and director and another director of the Company participated in the First Tranche and, as such, their participation each constituted a related party transaction as defined under Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions ("MI 61-101"). Such participation is exempt from the formal valuation and minority shareholder approval requirements of MI 61-101 as neither the fair market value of the securities acquired by the insiders, nor the consideration for the securities paid by such insiders, exceeds 25 per cent of the Company's market capitalization.

In addition to the applicable statutory hold period, securities issued pursuant to the Offering will be subject to an Exchange Hold for a period of four months from the date of issuance in accordance with the policies of the Canadian Stock Exchange.

About One World Lithium

One World Lithium Inc. is developing proprietary lithium extraction technologies and pursuing strategic partnership to commercialize lower-impact, scalable lithium production from brines and clay slurries. For more information, visit: https://oneworldlithium.com/.

On behalf of the Board of Directors of One World Lithium Inc.,

"Douglas Fulcher"

President and Chief Executive Officer

Prefacing with prior information from 9 days ago:
The important "rest of the story" you need to know regarding NRx Pharmaceuticals (NRXP) and the anticipated upcoming ANDA approval for no-preservative IV ketamine

Catalyst 1: ANDA approval

• Since all that was needed was an "attestation" from the luer lock vial manufacturer (see above link), I think the maximum time to approval would be akin to a Class 1 CRL, which is 60 days from the GDUFA meeting that took place on July 29.
• Approval can happen any day now. With great likelihood, it will be prior to Sep 30.
• Per the CEO, NRx is ready to ship vials in very large quantities. It will bring in substantial revenue.
• The potential for NRx to take a huge ketamine market share in a relatively short amount of time is REAL, as it's the ONLY preservative-free ketamine that will be available, it has a 100% domestic supply chain, and the ability to currently manufacture 1M vials per month, with room to increase production with a goal of eliminating shortages of this U.S. strategic drug.

Catalyst 2: NDA submission for NRX-100 (preservative-free IV ketamine formulation for psychiatric use)

• If they are granted Priority Review, the PDUFA date will be 6 months from the FDA's acceptance of the NDA, which could mean around April/May 2027.
• If they are granted the Commissioners National Priority Voucher (CNPV), which they have applied for, then the PDUFA date would be 60 days or less from the date of the FDA's acceptance of the NDA.
  • According to NRx, NRX-100 meets the criteria for the CNPV (which does not mean they will be granted it).
• NRX-100's NDA filing was originally projected for Dec 2025. The good news is the proposed indication was expanded earlier this year after a meeting with the FDA, likely causing much of the delay. The CEO recently alluded to the filing occurring very shortly (I believe it will be in Sep 2026). He confirmed NRx will be including the luer lock vial attestation from the manufacturer to avoid that snag for NRX-100.
• In the above link, there is a link to the Aug 10 NRx shareholder update call, where the CCO states the ketamine/esketamine market is projected to be $3B in 2027.

H.C. Wainwright, which tends to be on the high side of the price target range, reiterated their $45 PT a week ago. Last year, other analysts' PTs were between $25 and $34.

The share price should act accordingly upon ANDA approval with a very-near-term share price of $10 to $12 seemingly very reasonable based upon the facts and conservative projections.

LifeQuest World Corp Blog — September 1, 2026

The World Bank has projected that global water demand could outstrip supply by as much as 40% by 2030. That single number explains why municipalities, hoteliers, manufacturers, and real estate developers on nearly every continent are rethinking how they treat and reuse wastewater — and why "decentralized" treatment, once a niche approach, is becoming standard practice.

Traditional sewage treatment relies on large, centralized municipal plants and miles of connecting pipe — expensive to build and often impossible to retrofit into water-stressed regions fast enough. Decentralized systems flip that model: compact, on-site plants treat wastewater where it's generated, at a fraction of the infrastructure cost, and return clean water for irrigation, cleaning, or safe discharge almost immediately.

BioPipe Global, a wholly owned subsidiary of LifeQuest World Corp, has built its business around that shift. Its sludge-free, chemical-free, and odor-free treatment systems are already running in India, Bangladesh, South Africa, Ethiopia, and the Middle East. In India specifically, a new regulatory mandate requiring on-site sewage treatment plants at hotels — a sector responsible for roughly 10% of the country's sewage output — has driven fresh demand: BioPipe's joint venture partner, Environest Global, recently placed orders spanning 30, 50, and 100 cubic-meter-per-day systems for hospitality, residential, and educational projects. It's a useful case study in how a single policy change can ripple into real, measurable adoption of cleaner technology.

Wastewater treatment doesn't happen in isolation from the broader waste stream, either. Solids handling, compaction, and material recovery — the domain of LifeQuest subsidiary Compaction and Recycling Equipment Inc. (CARE) — are the other half of a genuinely circular environmental services model, moving waste out of landfills and back into productive use alongside cleaner water discharge. As more companies connect these pieces, the industry is edging closer to treating water and solid waste as one integrated resource-recovery problem rather than two separate ones.

We'll keep tracking these developments — regulatory shifts, new installations, and the companies driving them — in this space each weekday.

About LifeQuest World Corp LifeQuest World Corp (OTCID: LQWC) is a global technology company focused on low-cost, low-maintenance, eco-friendly decentralized wastewater treatment, alongside complementary environmental services in solid waste compaction and recycling. Through its subsidiaries, including BioPipe Global and Compaction and Recycling Equipment Inc. (CARE), the company works to expand access to clean water reuse and sustainable waste management worldwide. Learn more at www.lifequestcorp.com.

Trading Symbol: OTCID: LQWC

This blog is provided for general informational purposes about the wastewater treatment and environmental services industry. It does not constitute investment advice or an offer to buy or sell any security. Statements regarding future plans, projects, or industry trends may be forward-looking and are subject to risks and uncertainties; actual results may differ. Readers should consult publicly filed disclosures and a qualified financial advisor before making investment decisions.

As you can see above ADAR1 Capital Management has loaded over 1 million shares at current price levels! Yes, the price is nearly the same amount trading at $1.81 as I write this in after hours! TENX has over $200 million in cash, and they are trading with a 68 million market cap! Very undervalued at this price!!! That’s why institutional investors are so heavy invested and Webull puts the number at 103%

Mind you, there is a conference that the CEO is presenting at next week and I fully expect the share price to rise ahead of that event as people front load!

Take care and let’s win on another banger!! 🚀

Volatus Aerospace (TSX: FLT) just secured a place in Canada’s new Defence Drone Initiative Marketplace, giving it pre-qualified access to future procurement opportunities involving autonomous systems, counter-UAS, communications, integration, testing and training.

The timing is interesting. Over the past few months, FLT has opened a 53,000 sq. ft. Mirabel manufacturing facility, launched its proprietary V-Cortex autonomy platform, expanded allied defence partnerships, and entered Q3 with roughly C$59M in cash.

The bull thesis is simple: Canada is ramping defence spending and sovereign drone capability, while Volatus has already built the infrastructure needed to compete. What’s missing is a large contract.

If FLT lands a meaningful DND, NATO or U.S. defence award, the market may stop valuing it like a drone-services company and start treating it like an emerging defence platform.

That’s the re-rating setup.

Anyone have insight on $OLOX? It’s been slowly recovering for the last couple of hours after a prolonged sell-off. I’m in from near the lows and wondering if there’s any catalyst, upcoming filings, earnings, or news that could explain the recent price action.

I’ve been bullish on the ChefKart angle since the proposed GEAT acquisition was announced, and the latest update gives more substance to the thesis.

ChefKart just reported historical financial and unit-economic data, and the growth is pretty hard to ignore.

For 2026 YTD through July:
Recognized revenue: ₹6.52 Cr
Revenue growth: +224% YoY
2025 gross margin: 38%
2025 contribution margin: 10%
Average slot utilization: 79%
Average order value: ₹550

2025 recognized revenue was ₹4.83 Cr, meaning ChefKart has already generated more revenue in the first seven months of 2026 than it did during the entirety of 2025.

But the bigger opportunity for GEAT is the expansion potential.

ChefKart is still primarily concentrated in Delhi NCR, yet the platform has already built a meaningful operating base:
24,583 monthly bookings
70%+ repeat business
250+ active chefs and cooks
10 operating clusters
100,000+ families served
3M+ meals supported

Those numbers become much more interesting when you consider what happens if the same model is expanded into additional major Indian cities.
Delhi NCR → Bangalore → Mumbai → Hyderabad → other major metros.

India has an enormous and highly fragmented at-home food-services market. Building density in each city, expanding the chef network and increasing repeat usage could create significant operating leverage over time.

This is also why I like the two investment announcements around ChefKart.

Capital being deployed toward building and expanding the platform gives GEAT a much larger opportunity to work with rather than simply acquiring a small standalone business. If ChefKart can continue improving its unit economics while expanding geographically, the addressable market changes dramatically.

My valuation framework remains centered around a potential $50M ARR scenario.

Using a 10x revenue multiple, that would imply approximately a $500M valuation.

Obviously, this is an illustrative scenario and not a forecast. Getting there would require substantial execution, geographic expansion, customer growth and margin improvement.

The comparable-company side is what makes the upside interesting.
Urban Company has demonstrated how a fragmented offline services market can be organized through technology and scaled across India. Private companies such as Snabbit and Pronto also show that investors are willing to assign significant valuations to technology-enabled home-services platforms.

ChefKart is nowhere near the scale of Urban Company today, but that’s also where the asymmetry comes from.
At roughly $2M of current ARR, there is a lot of room for the business to grow before the opportunity starts approaching the scale of the larger Indian marketplace platforms.

For me, the bullish thesis is becoming increasingly straightforward:
Strong revenue growth + high repeat usage + expanding chef network + improving unit economics + a massive geographic expansion opportunity.
GEAT potentially gets exposure to all of that at a very early stage.

I’m still bullish on the ChefKart expansion.
The current business is small, but the market it’s entering is anything but.

Bitcoin Bancorp put out a Q2 update this morning and raised their full-year 2026 revenue outlook to $5.4–$5.5 million.

That’s more than double last year’s revenue and about 20% higher than their previous 2026 guidance. They say it’s coming from transaction activity across their Bitcoin ATM network, plus the Texas rollout and a move into Los Angeles.

They also mentioned adding more revenue through a Tangem collaboration for hardware wallets at the point of sale.

Drill results coming soon
Lots of drilling going on in Newfoundland
They have their ducks all lined up in a row
Gold is going to ten thousand dollars and more
Silver might be the place to make the real money
The other good play is the pot stocks like village farms and terrascend
Pot is going to be rescheduled and the pot stocks are going to pop

Saw BYRG pop up on my unusual activity scanner this morning and had to dig into it since nobody ever talks about this ticker. Turns out they just filed a name change with the Secretary of State (SOS). I picked up a tiny starter position just in case. It's currently moving on almost zero volume, so if this catches a bit of momentum or the right eyes find it, it could move incredibly fast.

*(If you would like to read my previous posts, f o l l o w m e!)*

Welcome to post #16.

In the last one I told you that Level 2 is kind of a superpower. It allows you to view the huge orders in the dark before the price even arrives.

However, there is a dark side to it. The experts, the showmen, and the traders are aware you're gazing at that screen. And they use it to play mind games with you.

A very illegal manipulation technique known as Spoofing. And despite the SEC's efforts to ban it, it simply occurs daily in the penny stock world.

Let me put a picture before you.

Suppose you paid $2.00 per share for a stock. It's doing great. It's grinding up to $2.20, $2.30. You are feeling good. You come to a Level 2 screen where you can find out what is waiting.

Now, all of a sudden, at $2.35, a big, huge, monstrous red order emerges from the screen. There are 1000000 shares for sale.

So the novice finds himself or herself in a quandary: what now? They panic.

They see that big wall of inventory and they say, "Oh my god, a whale is about to come dumping on us, the stock is about to tank, I need to get out now!

So the novice panics and sells at $2.30 to cash in their miniscule gains and get out of the game. Hundreds of other newbies roll that same, and they all panic-sell at the same time. All of this selling actually makes the stock go down to $2.15.

Then magically... something else happens.

That massive 1,000,000 share sell order at $2.35? It simply disappears! Poof. Gone.

It was never real.

The "whale" never intended to sell those shares. They simply displayed that huge order on the screen in an attempt to make you feel frightened to sell your shares. Why? Actually, they wanted to buy more stock, but the whale wanted it at a lower price!

They put you off your balance and lowered the price to $2.15, so you were led to believe that they were buying at a steep loss, but they were not.They scared you into selling, so they could buy all of your stock at a huge discount.

Boom. Stolen.

They do the exact same thing in reverse, too. They will make a huge fake buy order below the market price, to fool the newbies into believing that, "wow, there's lots of support! Better buy now!"* The second the beginners buy, the fake wall will vanish and the stock will plunge.

So, how can you beat a totally bogus screen?

You observe the orders and their behavior. If a big order is there but it sort of vanishes whenever the price nears the 5 cent mark… it's a spoof. They're afraid that it won't be fulfilled. It is simply a matter of getting the sheep together.

Real orders are not afraid.

So far, we've discussed only benefiting from a rising stock price. A buy low sell high mentality. However, there's an army of traders that make money when these trash companies drop to zero.

In post #17, we will be taking the curtain down on **Short Selling**.

Disclosure: I hold IMC shares. This is my personal opinion, not financial advice.

Today’s RNS looks more significant to me than a standard exploration update.

IMC’s 100% owned Armenian subsidiary, ASSAT, has signed a contract with TTH Limited covering three concrete workstreams at the Karaberd project:

• Laboratory reconstruction, increasing capacity to up to 30 samples per day
• A formal exploration programme
• Surface preparation involving the relocation of up to 5,000 tonnes of rock and ore for underground development

The work is expected to take roughly 2–3 months, with the contract valued at approximately €178,500.

The contract value itself is not the main point. To me, the important part is that IMC is moving from planning underground mining to physically preparing the site.

The company also says ore continues to be concentrated at approximately 4,000 tonnes per month and processed to 0.997 purity at the Masis plant. It expects to produce 50kg of gold over the next 12 months and is targeting 50kg of silver as well.

With the Karaberd licence renewed to January 2035 and gold extraction already having commenced, IMC increasingly looks like an early-stage producer rather than just an exploration story.

The risks are obvious: execution, funding, dilution, Armenian jurisdictional risk and the fact that the 50kg target is not guaranteed.

I’m still bullish, but I’m treating it as a speculative position.

RNS: https://www.investegate.co.uk/announcement/rns/imc-exploration-group-cdi---imc/karaberd-mining-contract-gold-production-update/9747146

VANCOUVER, BC AND MIAMI, FL / ACCESS Newswire / September 1, 2026 / Sekur Private Data, Ltd., a Swiss-hosted defense communications and cybersecurity company purpose-built for defense, intelligence community, government, and enterprise clients, (OTCQB:SWISF)(CSE SKUR)(FRA:GDT0) ("Sekur" or the "Company"), is pleased to provide a shareholder update on its past six months activities:

Dear Shareholders,

This year we set out to pivot the company to a better path to profitability - moving from a consumer privacy market that competes on price, to the customers whose need is most acute: government, defense and intelligence organizations, and the executives whose communications are actively targeted. The move started in the past twelve months and is now fully complete. Here is a summary of the last six months activities:

What we built
In February our portfolio was listed on the GSA Multiple Award Schedule through i3ICS (Contract 47QTCA18D0089), giving federal, state and local agencies a pre-competed path to purchase Sekur. In May we signed a defense distribution agreement with Elyon International, an SBA-certified woman-owned and veteran-owned small business with nearly thirty years of mission support experience, and in June a consumer demand partnership with AdRevv. We demonstrated live encrypted calling to invited defense and special operations guests in May and introduced our Controlled Unclassified Information capabilities to the Intelligence Community at the DIA's DoDIIS Worldwide Conference in August.

New website launched
In May we launched a rebuilt corporate website at https://sekur.com restructured to reflect our focus on high-net-worth individuals, corporations, and government, defense, intelligence and law enforcement agencies.Our investor relations website is now part of the new corporate site in this section https://sekur.com/en/company/investors .

Leadership and advisory appointments.

Selling into the defense and intelligence community requires people who understand how these organizations actually buy. Over four months in 2026 we announced the following appointments - serious people who joined because they believe the problem is real and they have validated our solutions:

• April 7 - Philip A. Oakley, appointed to the Strategic Advisory Board. A decorated intelligence professional and entrepreneur holding TS/SCI clearance, with dual master's degrees in Strategic Intelligence and National Security from the Joint Military Intelligence College and the Naval War College, and sixteen years in federal technology sales across a group of companies accounting for more than US$1.6 billion in sales.
• April 7 - Kenneth D. Rogers, appointed to the Strategic Advisory Board. A senior government and technology executive who served in Deputy CIO and IT comptroller roles at the U.S. State Department, overseeing an approximately US$1.3 billion budget and a US$3.8 billion IT portfolio, and leading enterprise IT strategy and acquisitions.
• April 20 - John T. Lewis, appointed Chief Technology Officer and Strategic Advisory Board member. A 34-year veteran of the CIA's Senior Intelligence Service and a Trailblazer Medal recipient, with deep expertise in secure systems and RF technologies.
• April 29 - Lt. Gen. Raymond Palumbo, U.S. Army (Ret.), appointed Chairman of the Strategic Advisory Board. Former Director for Defense Intelligence and commander of the Pentagon's ISR Task Force, following a distinguished career in special operations.
• June 18 - Nathan R. Price, appointed Special Advisor for Diplomacy and Intelligence. A former U.S. State Department foreign affairs analyst with over a decade of diplomatic experience, most of it in the Bureau of Intelligence and Research, who supported the final negotiations that ended the U.S. war in Afghanistan. A graduate of Georgetown University's Edmund A. Walsh School of Foreign Service.
• June 23 - Annette L. Redmond, appointed to the Strategic Advisory Board. A 40-year career across the U.S. Intelligence Community, the Department of Defense and the Department of State, most recently as Deputy Assistant Secretary for Intelligence Policy and Coordination in the State Department's Bureau of Intelligence and Research from September 2019 until her retirement in December 2023.
• July 7 - Chief Master Sergeant (Ret.) Rafael Beltran, appointed to the OpsTech Special Advisory Board. Former SOCOM Senior Technical Advisor to the CIO/J6 and executive communications chief.
• Other distinguished advisors are being added this year, to expand our reach in several sectors, nationally and internationally. Visit our new website section for Leadership for updates.

SekurOne. Our integrated platform - encrypted voice, video, email, messaging and VPN on our proprietary HeliX architecture - completed its first domestic and international encrypted calls this year, and paid beta clients onboard in September. SekurOne is ready for commercial launch on iOS and web in the first week of October at US$300 per month, with Android following in the first week of November, and conferencing and video completing the platform by the end of December.

Built in-house
We built encrypted voice across every major operating system on our own architecture rather than on licensed components - work that competitors relying on third-party stacks have not done. Defense and intelligence buyers evaluate a platform once, and we intend to arrive with one that performs.

On our numbers
In July we reported average revenue per user up 25% month over month as premium subscribers replaced legacy accounts. That is real progress, and it is also a ratio: it rises when we replace low-priced accounts and when those accounts simply leave. Our total revenue has declined during this transition, because we are shedding legacy subscribers faster than we are adding premium ones. That is the expected shape of this kind of shift. We expect revenues to increase as we start selling SekurOne licenses in Q4 2026, along with the continued replacement of legacy lower priced clients with premium clients.

Capital
We closed a non-brokered private placement of US$1,205,560 in January, with directors and officers participating alongside shareholders. In June we announced a further non-brokered placement of up to US$1,400,000, priced at US$0.07 per unit with a full warrant exercisable at US$0.10. Subscriptions are being received by investors, and we expect to close this placement before mid-December. Proceeds are directed to SekurOne commercialization and our U.S. government and corporate sector sales effort.

What comes next
Management currently estimates that approximately 200 SekurOne subscribers - roughly US$60,000 in gross monthly recurring revenue - would bring the Company to profitability. Management has high confidence that it can achieve these numbers organically or through a government contract within 6 months from our October 2026 launch of SekurOne, and has already started pre-sales for SekurOne in the USA. Internationally, the solution is being presented in Switzerland and Africa ahead of its launch. The milestones ahead are specific: beta clients onboarded from md-September, commercial launch in October, and above all our first named government or defense contract, whether in the United States or Africa. Everything described above exists to produce that outcome. We have built the apparatus; we now have started to use it.

Africa
Our Africa division has moved quickly this year. The July cyberattack on Unitel, Angola's largest operator, disrupted mobile voice, data and internet nationwide for twenty-three days across a subscriber base of more than 21 million - a demonstration of how much depends on a single carrier, and of why government and corporate users need communications that do not rely on that infrastructure. Interest has followed. Our Africa Director of Operations, Christophe Kabeya, is in Angola to discuss a possible nationwide exclusive partnership with a partner and we expect a final resolution by the end of September, at which time we will make a public announcement with more details. In the Democratic Republic of Congo, we have received a positive recommendation from a government security body and await official confirmation before opening discussions on commercial terms for Sekur licences.

Private sector
We are preparing to introduce SekurOne to high-net-worth individuals and businesses in the sports and entertainment industries through our network of referral partners. We have identified several targets and prospective VIP clients in those sectors and are preparing the supporting documentation now to be ready for October launch.

Management believes very strongly in the future of the Company and has backed that belief with its own capital. Members of management purchased shares in the open market in six separate months this year - January, February, March, May, July and August - and directors and officers subscribed alongside shareholders in the January placement. There have been no insider sales. These transactions are a matter of public records in our SEDI filings.

We are grateful for your continued support and do not take it for granted. Feel free to email us at investors@sekur.com with any questions or comments.

On behalf of the Board of Directors and management
Alain Ghiai, Chairman and CEO
SEKUR PRIVATE DATA LTD.

About Sekur Private Data
Sekur Private Data is a Swiss-hosted cybersecurity, defense communications, and privacy solutions provider, offering a secure suite of tools to protect governments, defense and federal agencies, businesses, and individuals from unauthorized access and cyber threats. With capabilities such as SekurOne, SekurMail, SekurMessenger, and SekurVPN, Sekur provides a reliable and secure means of digital communication and data storage for Controlled Unclassified Information (CUI), classified-adjacent and civilian communications use, grounded in Swiss privacy standards with on-premises infrastructure for government agencies, allowing for data sovereignty. Sekur sells its solutions through its website www.sekur.com, approved distributors and telecommunications companies globally, and through the U.S. General Services Administration (GSA) Multiple Award Schedule (MAS), Contract No. 47QTCA18D0089 serving governments, defense institutions, federal agencies, businesses, and consumers worldwide. Sekur's main sales operations are in Miami, USA.

This is sponsored content. Investors should conduct their own due diligence and consult a qualified financial advisor before making any investment decisions.

VLN^® Category Leader Accelerates 2H 2026 Growth Phase as Same-Store Sales Climb

22nd Century Accelerates 2H 2026 Commercial Execution

MOCKSVILLE, N.C., Sept. 01, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), the leader in low-nicotine tobacco, low-nicotine cigarettes and the only tobacco products company focused on reducing the harms of smoking through nicotine reduction, today issued the following letter to stockholders from Lawrence Firestone, the Chief Executive Officer of 22nd Century Group, Inc.: 

2026 Mid-Year Strategic Update Shareholder Letter

Dear Shareholders,

At 22nd Century Group, we believe long-term shareholder value is created when a company has a clear mission, a differentiated product and strategy, and the discipline to execute. Our mission remains unchanged: to help adult smokers combat the harms of tobacco and nicotine. As the architect of the newest category for smoking harm reduction, the low-nicotine category, our strategy is rooted in our proprietary low-nicotine tobacco platform that fills a unique place in the market, the industry and society. Our VLN^® cigarettes remain the first and only low-nicotine combustible cigarette authorized by the U.S. Food and Drug Administration specifically to reduce the harms of smoking by helping smokers smoke less.

Over the past several months, we have been setting that foundation through disciplined execution, expanding the classes of trade we sell through, strengthening retail availability and consumer awareness, improving our product portfolio, and continuing to invest in low-nicotine technology. Today our focus is squarely on execution: expanding commercialization of our Pinnacle and VLN^® brands, improving the economics of the business, and positioning the Company for sustainable, profitable growth.

This is how we win and how we create long-term shareholder value and, over time, increased market capitalization.

We Win by Expanding Our Retail Presence — 2,000 Outlets Today, ~5,000 by Year-End

Consumers are already supporting our brands in approximately 2,000 retail outlets across the US and several of our newest adult consumers have told us how satisfied they are with switching to VLN^® cigarettes. The word has begun to travel through consumers and our marketing initiatives will continue to drive awareness and trial.

To build on that demand, we recently launched Pinnacle Pure alongside Pinnacle VLN^® in states that have authorized these products, broadening the value-driven Pinnacle brand. We are now taking both product families into California through an initial retail trial, as well as into the high-visibility markets of metro New York and northern New Jersey. This will be followed in the fourth quarter of 2026 with a new digital convenience platform offering direct to consumer home delivery of our products.

Investors will see additional announcements in the second half of 2026 on wins by expanding our distribution network. As our footprint grows to approximately 5,000 outlets by year-end, we are strengthening not only the category itself, but also 22nd Century's leadership position within it.

We Win by Driving Commercial Execution That Can Scale

Winning in this business requires more than innovation. It requires execution in distribution, on the shelf, and through consumer adoption and repeat purchase. That is why we remain focused on building a stronger branded products business with increasing retail presence, led by our Pinnacle portfolio, better trade execution, and stronger support for our commercial partners.

We offer the only low-nicotine cigarette which is in a familiar form to smokers, and with a recognizable brand, national distribution and disciplined shelf placement, this will enable the opportunity for trial and improve repeat purchase and revenue over time for our VLN^® cigarette products.

We are now measuring early data on rate of sale. Since the beginning of the year, same-store sales have been growing each month, and we have seen VLN^® cigarette trial turn into carton purchases rather than individual packs. Data from retail point-of-sale is showing that volume has grown consistently by an average of 10% per month in non-promotion periods, and we estimate now that active VLN® user trial exceeds 5,000 cases and continues to grow monthly.

Our goal is to build consumer awareness, smoking consumer adoption and brand loyalty. Then while rate of sale improves, reorder patterns and revenue will become more consistent, our platform will become increasingly more valuable to customers, retailers, and shareholders alike.

We Win by Improving the Economics — Gross Margin

One of our most important priorities has been improving the economic quality of our revenue. Shifting the mix of our revenue to our branded portfolio is our primary focus. Then, as we grow our branded products that carry positive gross margins will continue to drive profitability. This shift is occurring in the third quarter 2026 and will continue as we go forward, but remains dependent on consistent volume for our factory of our branded products.

We Win by Building More Than a Single Product

Our long-term opportunity extends beyond our current family of VLN^® products and will leverage our robust IP portfolio. We are building a broader platform appealing to different consumer brand choices. This will allow us to grow the low-nicotine category by expanding our VLN^® product offerings and form factors, supporting additional partner opportunities, and selectively pursuing ways to leverage our proprietary low-nicotine technology more broadly.

We believe this platform approach is important because it creates multiple paths to value. It allows us to drive toward the long-term strategic value in the foundation that we have built. Over time, we believe successful execution across these fronts can translate into stronger business performance, broader investor recognition, and a more appropriate market valuation for the Company.

This Is How We Create Long-Term Shareholder Value in the >$50 Billion US Market

Our path forward is grounded in a large, unserved market of smokers seeking a low-nicotine combustible alternative to their current brands, a market we currently serve alone. Consumers have found our products on the shelf, and adoption is growing each month. With a base of repeat consumers in place, we will introduce marketing and consumer engagement programs to drive accelerated awareness and adoption while maintaining pricing discipline.

While building a new category takes persistence, 22nd Century is the clear leader and has a real opportunity to capture a meaningful portion of the estimated >$50 billion annual US combustible cigarette market at retail. Every pack we sell to build the low nicotine category is a share shift. We do not view our initiatives as isolated efforts. Rather, they are connected parts of one overarching value creation strategy.

On behalf of the Board of Directors and the entire 22nd Century team, thank you for your continued support and confidence.

Sincerely,

Lawrence D. Firestone
Chairman and Chief Executive Officer
22nd Century Group, Inc.

About 22^nd?Century Group, Inc.
22nd Century Group is pioneering the tobacco harm reduction movement by enabling smokers to take control of their nicotine consumption. 

Our Technology is Tobacco
Our proprietary non-GMO reduced nicotine tobacco plants were developed using our patented technologies that regulate alkaloid biosynthesis activities resulting in a tobacco plant that contains 95% less nicotine than traditional tobacco plants. Our extensive patent portfolio has been developed to ensure that our high-quality tobacco can be grown commercially at scale. We continue to develop our intellectual property to ensure our ongoing leadership in the tobacco harm reduction movement. 

Our Products
We created our flagship product, the VLN^® cigarette using our low nicotine tobacco, to give traditional cigarette smokers an authentic and familiar alternative in the form of a combustible cigarette that helps them take control of their nicotine consumption. VLN^® cigarettes have 95% less nicotine compared to traditional cigarettes and have been proven to allow consumers to greatly reduce their nicotine consumption. 

FDA Authorized
Our VLN^® cigarette is the only low nicotine combustible cigarette authorized by the FDA in the United States. 

VLN^® is a registered trademark of 22nd Century Limited LLC. 

Learn more at?xxiicentury.com, on?X (formerly Twitter), on?LinkedIn, and on?YouTube. 

Learn more about VLN^® at tryVLN^®.com. 

Read the Full Press Release & Disclaimer

https://marketwirenews.com/stock/xxii/news/22nd-century-ceo-chairman-larry-firestone-improved-g-6532804588247688.html

Not financial advice. Tiny cap. Dilution is real. LOIs can die. Read the filings. Then look at what they just put out.
Olenox (NASDAQ: $OLOX) used to be Safe & Green / modular construction. Under McLaren they rebranded and started stitching together gas, behind-the-meter power, bitcoin/high-density compute, and applied AI.
Their own line from the Aug 26 shareholder letter: energy → power → compute → intelligence.
Market cap has been hanging around a couple million while they keep printing platform PRs. That’s why this thing can rip on headlines.

1) CS Digital closed May 26
$30M deal ($14M preferred + $16M note, plus warrants and up to $20M contingent).
What they bought, per the deal coverage:
• digital infrastructure / mining platform
• 35 MW installed capacity
• sellers cited $20.6M 2025 revenue and $6.2M 2025 EBITDA
• CS Digital co-founder Bernardo Schucman (ATL Data Centers → that platform later went into CleanSpark / $CLSK)
• stated target: all-in power under $0.02/kWh on off-grid, gas-powered sites
Stock ripped ~62% after-hours on the close. They’re still hosted at third-party sites for now. The thesis is moving mining onto their own gas.

2) They are already printing BTC
Not “we will mine someday.”
• June + July: ~17 BTC per month average
• they framed that at ~$72k/BTC gross
• May was the first operating update after close (June 2 PR)
• July production PR dropped Aug 20
That’s a live digital-infra run-rate sitting on a microcap.

3) Wildboy + IPD LOI — Aug 19 — this is the juicy one
Non-binding LOI to buy Wildboy Holdings + IPD Industries for ~$20M, mostly preferred + some common/cash. Target close on or before Oct 31, 2026. Independent engineering review already started.
Seller-described assets (they flag this as diligence-gated):
British Columbia (Wildboy)
• gas plant with stated processing capacity up to 144 MMcf/d
• interests tied to 180,000+ acres
• existing wells represented at up to ~18 MMcf/d
• management estimate: that gas could support ~90 MW of gas-fired generation
West Texas / Waha Hub / Delaware Basin (IPD)
• 5,000+ acres near Waha outside Pecos
• fiber, water, substations reportedly 1.5–2.5 km from certain tracts
• QSE / REP / ERCOT market-ops angle
• sellers have floated a long-term generation range of 1–5 GW (not a committed build)
Near-term plan if the deal and engineering clear: evaluate an initial ~20 MW self-hosted bitcoin mining + hosting site. That’s the first step off third-party hosting and onto their own molecules.
If even a sliver of the Waha + BC story survives diligence, this is no longer “old modular co with a mining side hustle.” It’s a stranded-gas-to-AI-power story.

4) PsyLinks — July 13 — the intelligence layer
Closed PsyLinks Neurotech for ~$500k in restricted stock. Two PhDs came in as VP Technology and VP Product Development. Pitch: neuroscience + multimodal sensing + ML + closed-loop systems.
Fits the letter. They’re not just trying to sell electrons. They’re trying to sit on the stack from wellhead to workload.

5) The numbers in the Aug 26 letter
Q2 2026 (three months ended June 30):
• Revenue ~$2.1M, up ~194% vs ~$721k a year ago
• Assets ~$64.2M, up ~78% from YE 2025
• Equity ~$19.4M, up ~155%
Aug 6 they regained Nasdaq periodic-filing compliance. That matters. This name has been one missed filing away from a mess.

Why bulls are loud
AI data centers are power-constrained. Grid interconnects take years. Cheap, dispatchable, behind-the-meter gas is the cheat code every miner and AI-host wants.
$OLOX is trying to own:
1. the gas
2. the generation site
3. the miners / hosts
4. a software/intel layer on top
CS Digital gave them operating compute now.
Wildboy/IPD is the attempt to give them cheap power + land + midstream optionality.
PsyLinks is the “we’re not just a hashrate box” piece.
Q2 shows the balance sheet and top line already moving after CS Digital.
Compare the stated asset stack and BTC run-rate to a micro market cap. That’s the whole trade.

By Alex Rivera, Unicorn Analytics

For Hong Kong investors, the central question raised by a U.S. patent litigation of the Hong Kong-listed Shenzhen Creality 3D Technology Co Ltd (03388.HK) is not who will ultimately prevail at trial. It is whether the company has given the market sufficiently specific, accurate and timely information as the case has evolved.

Creality listed on the Stock Exchange of Hong Kong in May 2026. In its IPO prospectus it described a U.S. patent dispute involving certain 3D-scanning patents and products, noted a mixed summary-judgment outcome, and concluded that any potential liability was immaterial. It pointed to limited recent sales of the accused scanners, the cessation of those products, a supplier indemnity and legal advice.

The prospectus did not name the plaintiff, Artec Europe, or the case number, and it incorrectly referred to the forum as a New York State court rather than the federal court in the Eastern District of New York.

After public questions during the offering period, Creality issued a clarification in early June restating that the matter had already been disclosed and would not have a material adverse effect. Its subsequent interim results continued to treat the litigation as immaterial and reported no material subsequent events after 30 June, even though a significant court ruling had intervened in July.

That July ruling is the most consequential recent development. On 23 July the U.S. court excluded Creality’s damages expert, finding his reasonable-royalty analysis fundamentally flawed because it relied on a non-arm’s-length cooperation agreement between the defendants that was neither a patent licence nor a proper benchmark. At the same time the court allowed Artec’s damages expert to testify. The practical effect is an asymmetry: Artec retains expert support for its damages case while Creality cannot rely on the excluded analysis.

The procedural posture of the patents themselves also requires precise description. In April 2026 the court granted Creality summary judgment of no literal infringement on one of the three patents. It did not, however, remove that patent from the case. The court directed that claims under all three patents proceed to trial: literal infringement claims on two patents and, to the extent asserted, infringement under the doctrine of equivalents on the third.

Creality later moved to strike the doctrine-of-equivalents theory and the willfulness allegations that can support enhanced damages. Those motions remain pending. Artec has opposed the doctrine-of-equivalents motion and was due to respond on willfulness. None of these applications has been granted, and the issues are expected to be tried.

Against this background, Creality’s materiality assessment rests heavily on two pillars: the disclosed sales figures and the advice of counsel. Both invite scrutiny.

The sales numbers cited in the prospectus cover 2023 to 2025, a period after successor products had begun to replace the accused models. They therefore capture the tail of the products’ commercial life rather than the years when those models were the primary offerings. Early litigation records also show substantial crowdfunding activity for one of the products before a court-ordered freeze. In addition, Creality faces potential joint and several liability with its co-defendant, and the question of willfulness remains live. These factors suggest that the disclosed recent sales figures alone may not fully capture the scale of possible exposure.

The counsel pillar has also shifted. The July ruling removed the defendants’ damages expert from the case. New counsel appeared for Creality and its co-defendant in August. Assessments prepared under the previous representation, particularly those that rested in part on the now-excluded expert analysis, at least warrant fresh evaluation. Creality has not issued a further voluntary announcement addressing the July order.

Materiality is not frozen on the date a prospectus is signed. Low recent sales of specific products are a relevant quantitative input, but they are not the only one. When claims under all three patents remain headed for trial, when the damages-expert field has become asymmetric, and when potential remedies include royalties, enhanced damages or injunctive relief, qualitative factors also matter: the strategic importance of the technology, reputational effects, management attention, the strength of any indemnity, and the company’s broader intellectual-property position.

None of this predicts the outcome of the January 2027 trial or establishes that the litigation will prove financially material. Creality continues to contest liability and the scope of the claims. The court has not found infringement. Yet the record shows a case that has continued to develop after the prospectus and the June clarification.

For a newly listed company that emphasises innovation in scanning and related ecosystems, the gap between a risk mentioned in a long document and a risk explained with sufficient specificity and currency is a legitimate subject for investor attention.

Clear disclosure is the mechanism through which markets assess and price risk. When court developments alter the picture, the information available to investors should keep pace.

$ZENA is hitting the road this month to showcase their drone technology! Great opportunity to get new eyes on the company.

ZenaTech to Showcase Drone as a Service Growth and ZenaDrone Defense Solutions at Series of U.S. and Global Investor and Defense Events

https://finance.yahoo.com/technology/ai/articles/zenatech-showcase-drone-growth-zenadrone-114500394.html

TLDR: PSNL looks like an opportunity with very limited downside risk (low single digit %) due to an earlier merger agreement with Tempus and yet potentially triple digit % return if the merger deal is to fall through, which looks increasingly likely after the Moderna cancer vaccine update.

Guys, I think I just noticed a textbook case of reflexivity - PSNL, Personalis.

This tiny and very little known company powers the engine behind the recently hyped Merck-Moderna cancer vaccine.

Despite the huge revenue upside from the vaccine, the stock has barely performed after the news, due to its previous merger agreement with Tempus at $16.25, which was BEFORE the vaccine update and is still pending shareholders’ vote.

This is where things get interesting- after the vaccine news, PSNL stock broke through $16.25 and has been trading at a slight premium over the buyout price for 8 days in a row. And over 40% of outstanding shares have been traded above the buyout price as of yesterday. IF the deal were to even get to shareholder voting stage, I think the vast majority, if not all, of the shares traded above this level will vote no.

Due to its tiny scale and the huge revenue upside from the vaccine, I think it’s safe to assume impressive returns if the deal was to fall apart. And the more shares traded above the buyout price and the higher the share price goes, the less likely is the merger to go through. The situation feels exactly like what George Soros described in Alchemy of Finance - the higher the volume and share price, the higher the share price will climb. And based on its recent trading, I think some big boys might have been making this bet.

The shares trades at only about 3% premium over $16.25, worth taking a shot? Any thoughts?

Up 18% today and might very well be heading back to its 52 week. That’s a 500% gain. My bet is that it will soon be mentioned right along with MP and USAR when America rare earths companies are discussed. One of the largest rare earths magnet 🧲 manufactures within the year. Meme candidate.

(If you are interested in my previous posts, f o l l o w m e!)

Welcome to post #14.

In the last one I told you that I would give you the one indicator you really need in your chart at the end of the last one. Seemingly a single line that's like a ‘lie detector’ for the entire marketplace.

It is known as Volume Weighted Average Price. It's a no-brainer, they all just say VWAP, which stands for "vee-wap.

Seems like a very technical and complicated process, doesn't it? It's really not.

The majority of beginners just put a random "Moving Averages" indicator on their chart because some random guy on YouTube said to do it. However, a regular moving average is a semi-intelligent algorithm. Simply averages the price of the stock from the past several hours. It doesn't matter how many 1 shares were traded or how many 10 million shares were traded.

VWAP isn't like that. It does consider the Volume actually.

It takes into account the actual number of shares bought and sold and computes the actual, exact average price that each and every person in the entire market paid for that stock today.

It's used by every single professional day trader and institutional computer algorithm, given that it's merely hard volume data. Which makes it become a self-fulfilling prophecy.

The only rule to keep in mind with VWAP: it is the ultimate line of tug.

When the stock price is trading above the VWAP, it indicates bulls are in control. The stock is strong. The people are making money.

When the stock price is stuck below the VWAP line, it means the sellers have the upper hand. The stock is weak. The majority of those who purchased today now find that they are losing money and are panicking.

Recall what Support and Resistance was in post #7? VWAP is similar to a big moving average floor or ceiling that moves throughout the day in line with the price.

If a penny stock rallies at 9:30 AM, drops, and remains below the VWAP for 2 hours, then do not touch it. I'm not worried about the price of it being cheap. It is dying.

But, what happens when a stock has been languishing below the VWAP all day, and then at 11:00 AM, it explodes upward with a ton of volume, and it pierces the VWAP line?

It's when professional attention is needed. The stock has just gone from a weak to a strong position. Now, if it reverses and sets up the VWAP line as a new support level, right? (Just as we discussed in post #9)? It's one of the best winning systems in the penny stock game as a whole.

So, now you have your candlesticks, your volume bars, your support and resistance floors, and your VWAP line. Your chart is pretty much a professional chart.

A chart is only a look at the past.

What about having a glimpse inside the market, and seeing the big, hidden sell orders waiting for you, before you ever get there?

In post #15, we'll be discussing data type #2. It is similar to the green scrolling text in the movie The Matrix, but it will save your life!

AXG is a Hong Kong-based regulated fintech that has shifted hard into digital asset infrastructure and AI services. Think stablecoin issuance, treasury and payments rails, RWA tokenization, plus AI agent tools. Their stated goal is “mobilizing tokens 24/7.”

The standout piece is regulatory. In June 2026 their subsidiary AX Coin Bahrain received a full Central Bank of Bahrain Stablecoin Issuer license. That is the first under the CBB’s dedicated framework. They also secured Sharia-compliant certification. Bahrain is small as a consumer market but deep as a wholesale and Islamic finance hub with real banking depth and GCC payment connectivity. The license is a real foundation. The next steps are product approval, terms, issuance, and actual adoption.

The bullish angle centers on planned AXUSD. Unlike USDT (no yield to holders on reserves) or USDC (same basic model), AXUSD is designed around a regulated reserve-sharing mechanism under CBB rules. Eligible participants, the exact formula, and rights are not yet public and still need approval. In the US, payment stablecoin issuers are restricted from paying yield just for holding. Bahrain’s framework allows passive returns from reserve interest or Sharia-compliant rewards, treating such a product as a security. That creates a potential economic difference if they can get the product live, funded, and distributed.

Scale of the backdrop is large. Stablecoin market cap sits around $304B. Holder address estimates run into the hundreds of millions (with the usual caveats that addresses are not unique people). Adjusted volumes are already in the multi-trillion range annually. Citi’s 2030 base case points to roughly $1.9T outstanding and very high transaction activity; the bull case is higher. Cross-border payments run in the hundreds of trillions. Remittances alone are hundreds of billions per year with meaningful friction costs. RWA tokenization and AI-agent payments add more layers. None of that is automatic revenue for AXG, but it shows why regulated digital dollar infrastructure and compliance layers matter.

Current company numbers: FY26 revenue about $28M (roughly 9x prior year), driven heavily by AI infrastructure fees. Net loss around $13M as they invest. They reported $226M in payment volume on AX ONE, $52M across 10 RWA projects, and meaningful assets under administration growth. Effective indirect ownership of the Bahrain issuer sits around 60-61%. Market cap has been in the mid-$400M range recently (price around $2.34 in recent screens). They have named financing, banking, and technology partners plus some operating clients, though concentration exists and AXUSD itself is still pre-commercial.

The thesis is that a CBB-approved product with differentiated economics, plugged into payments, treasury, and Know-Your-Agent style compliance tools, could sit in a growing institutional stack. Execution is the hard part: final terms, reserves, redemption, liquidity, partners, users, and multi-jurisdiction scaling. USDT and USDC already have massive scale. PayPal, Stripe, Visa and others are active in the category. Dilution and ongoing investment are real factors for equity holders.

Not advice